To include your compound in the COVID-19 Resource Center, submit it here.

Gazyva: Interim Phase III data

Interim data from 1,202 patients with previously untreated follicular lymphoma in the open-label, international Phase III GALLIUM trial showed that Gazyva plus chemotherapy followed by Gazyva

Read the full 264 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE